May 25, 2021
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Attn: | David Gessert |
Re: | Reviva Pharmaceuticals Holdings, Inc. |
Registration Statement on Form S-1, as amended (File No. 333-255323)
Ladies and Gentlemen:
As the underwriter of the proposed offering of Reviva Pharmaceuticals Holdings, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 5:00 p.m., Eastern Time, on May 26, 2021, or as soon thereafter as is practicable.
The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours, | ||
Maxim Group LLC | ||
By: | /s/ Clifford A. Teller | |
Name: Clifford A. Teller | ||
